Related Experiment Video
Updated: Aug 15, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
[Epidemiological and clinical outlook of chronic Chagas' heart disease in Mexico]
Justo Sierra-Johnson1, Amonario Olivera-Mar, Víctor M Monteón-Padilla
1Instituto Nacional de Cardiología Ignacio Chávez, Mexico, DF, Mexico.
Insights
Chronic Chagas' heart disease, caused by Trypanosoma cruzi, is a significant cause of dilated cardiomyopathy. This study highlights its distinct epidemiological and clinical features compared to other cardiomyopathies.
Area of Science:
- Cardiology
- Infectious Diseases
- Epidemiology
Background:
- Dilated cardiomyopathy is a significant cause of heart failure.
- Chagas' disease, caused by *Trypanosoma cruzi*, is a leading cause of heart disease in endemic regions.
- Understanding the specific characteristics of Chagas' heart disease is crucial for diagnosis and management.
Purpose of the Study:
- To compare the epidemiological and clinical profiles of chronic Chagas' heart disease with other forms of dilated cardiomyopathy.
- To identify distinguishing features of Chagas' heart disease.
Main Methods:
- A retrospective study of 128 patients (51 *Trypanosoma cruzi* positive) from 1993-2003.
- Data collection included interviews for epidemiological data and health service records for clinical and serological information.
- Statistical analysis employed Chi-square, Fischer, Mann-Whitney, Student's t-tests, and multivariate analysis.
Main Results:
- Chagas' disease patients were older (55 vs. 42 years), more likely from rural areas (90% vs. 68%), and lived in poorer, crowded conditions.
- ECG abnormalities (rhythm, conduction) and pacemaker use were more common in Chagas' patients (84%, 78%, 24% vs. 55%, 64%, 10%).
- Congestive heart failure was more frequent in other cardiomyopathies (88% vs. 71%), while comorbidities were rarer in Chagas' disease.
Conclusions:
- Chronic Chagas' disease is the predominant cause of dilated cardiomyopathy at the study hospital.
- Given its regional prevalence in Mexico, Chagas' disease warrants targeted attention and control strategies.
- Effective control programs, successful elsewhere, should be considered for implementation.
Objective:
To compare the epidemiological and clinical characteristics of chronic Chagas' heart disease to other dilated cardiomyopathies.
Methods:
A study comprising 128 patients from a heart disease center was carried out from 1993 to 2003. Of them, 51 (40%) were Trypasonoma cruzi positive. Epidemiological data was obtained through interviews and clinical and serological data from health services. Statistic analysis was conducted using the Chi-square, Fischer, Mann-Whitney or Students' t-test as well as multivariate analysis.
Results:
Chronic Chagas' disease patients were older (55+/-10 years old) than those patients with cardiopathy (42+/-17 years old). Most of them were born in rural areas (90% vs 68%), lived in poor (75% vs 16%), crowded households (45% vs 20%), together with domestic animals (71% vs 61%) and were aware of the Chagas' vector (73% vs 25%). Rhythm and conduction ECG abnormalities as well as permanent pacemaker were common among Chagas' patients (84% vs 55%, 78% vs 64% and 24% vs 10%, respectively). Congestive heart failure was more frequent among cardiomiopathy patients (88% vs 71%). Both groups had abnormal myocardial perfusion with normal epicardial arteries. Comorbidities were more frequent in cardiomiopathy patients than in chronic Chagas' disease patient (two cases only).
Conclusions:
Chagas' disease is the most common cause of dilated cardiomiopathy in the study hospital. Due to its regional distribution in Mexico, it deserves special attention and control programs proven to be effective in other countries.
Related Concept Videos
American Trypanosomiasis
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Endocarditis II: Clinical Features of Infective Endocarditis
Heart Failure III: Clinical Manifestations

